Biogen Price Chart
Biogen Volume Chart
Biogen Market Segments
After Hours
| Open | $205.99 |
|---|---|
| Close | $210.74 |
| Low | $205.99 |
| Low Change | 0.00 (0.00%) |
| High | $210.74 |
| High Change | +4.75 (+2.31%) |
| Range | $4.75 |
| Volume | 255.466K |
| Dollar Volume | $53.84M |
Regular Trading Hours
| Open | $209.44 |
|---|---|
| Close | $206.06 |
| Low | $203.40 |
| Low Change | -6.04 (-2.88%) |
| High | $215.79 |
| High Change | +6.35 (+3.03%) |
| Range | $12.39 |
| Volume | 875.257K |
| Dollar Volume | $180.36M |
Premarket
| Open | $209.78 |
|---|---|
| Close | $209.36 |
| Low | $207.11 |
| Low Change | -2.67 (-1.27%) |
| High | $209.78 |
| High Change | +0.00 (+0.00%) |
| Range | $2.67 |
| Volume | 1.11K |
| Dollar Volume | $232.39K |
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $205.99 |
|---|---|
| Close | $210.74 |
| Low | $205.99 |
| Low Change | 0.00 (0.00%) |
| High | $210.74 |
| High Change | +4.75 (+2.31%) |
| Range | $4.75 |
| Volume | 255.466K |
| Dollar Volume | $53.84M |
Regular Trading Hours Yesterday
| Open | $209.44 |
|---|---|
| Close | $206.06 |
| Low | $203.40 |
| Low Change | -6.04 (-2.88%) |
| High | $215.79 |
| High Change | +6.35 (+3.03%) |
| Range | $12.39 |
| Volume | 875.257K |
| Dollar Volume | $180.36M |
Premarket Yesterday
| Open | $209.78 |
|---|---|
| Close | $209.36 |
| Low | $207.11 |
| Low Change | -2.67 (-1.27%) |
| High | $209.78 |
| High Change | +0.00 (+0.00%) |
| Range | $2.67 |
| Volume | 1.11K |
| Dollar Volume | $232.39K |
Biogen News
3 days agoinvesting.comBiogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox
3 days agoinvesting.comBiogen stock rises on positive Alzheimer’s drug trial data
4 days agobarrons.comBiogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
4 days agoinvesting.comWhy is Biogen stock rallying today?
5 days agoinvesting.comTruist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key data
5 days agobarrons.comBiogen Stock Is Upgraded to Buy Ahead of Key Alzheimer’s Drug Study Details
5 days agobarrons.comCan Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
2 months agoinvesting.comBiogen advances Alzheimer’s drug after mid-stage trial results
2 months agoinvesting.comWhy is Biogen stock surging today?
2 months agoinvesting.comBiogen stock jumps 10% on positive phase 2 diranersen data for Alzheimer’s
Biogen Top Trades
Biogen's top trade so far today returned +4.19%, while the top short trade returned -4.54%.
Biogen Moving Averages
| 5 Day Moving Average (SMA5) | $201.29 |
|---|---|
| 10 Day Moving Average (SMA10) | $203.60 |
| 20 Day Moving Average (SMA20) | $204.42 |
| 50 Day Moving Average (SMA50) | $198.50 |
| 100 Day Moving Average (SMA100) | $191.55 |
| 200 Day Moving Average (SMA200) | $180.19 |
Biogen Statistics
| Average Volume (30 Days) | 1.37M |
|---|---|
| P/E Ratio (Current) | 21.23 |
| EPS (Current) | $9.29 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $2.43B |
| Cash Ratio | 1.13 |
| Current Ratio | 3.06 |
| Quick Ratio | 2.41 |
| Debt to Equity | 0.34 |
| Enterprise Value | $32.03B |
| EV to EBITDA | 11.66 |
| EV to Sales | 3.22 |
| Price to Book | 1.56 |
| Price to Cash Flow | 11.20 |
| Price to Free Cash Flow | 11.97 |
| Price to Sales | 2.93 |
| Return on Assets | 0.05% |
| Return on Equity | 0.07% |
Biogen Stock Splits
There have been no stock splits for Biogen (BIIB).
Biogen Dividends
There have been no dividends for Biogen (BIIB).